Stay updated on RST-001 Trial for Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page.

Latest updates to the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for AbbVie’s completed AGN-151597 trial for advanced retinitis pigmentosa, including eligibility, study design, outcomes, locations, and study documents.SummaryDifference68%

- Check19 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2 while the study page remained a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now renders a 403 Forbidden error, indicating restricted access to the study record. The 403 content is presented with the site's header and footer intact.SummaryDifference21%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor template/system update. This change does not alter the study details or user-facing content on the page.SummaryDifference0.1%

Stay in the know with updates to RST-001 Trial for Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page.